Skip to content

Dose defunctioning stoma better than anastomosis reinforcement in a radical surgery for low rectal cancer? A prospective randomized single center study

Dose defunctioning stoma better than anastomosis reinforcement in a radical surgery for low rectal cancer? A prospective randomized single center study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17011810
Enrollment
Unknown
Registered
2017-06-29
Start date
2018-01-01
Completion date
Unknown
Last updated
2017-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rectal cancer

Interventions

Sponsors

Shanghai Changzheng Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Aged 18-75 years old; 2) ECOG physical condition score 0-1 points; 3) Primary rectal cancer confirmed by pathology; 4) The distance from the lower edge to the mass is between 5-8 cm; 5) General anesthesia is can tolerated; 6) Patient and family members are able to understand the research program and are willing to provide written informed consent.

Exclusion criteria

Exclusion criteria: 1) already received neoadjuvant radiotherapy; 2) with a TNM stage at T4b; 3) accompanying other malignant neoplasms at the same time; 4) history of pelvic surgery; 5) expand radical surgery is necessary; 6) severe edema in proximal colonic; 7) more than one anastomose during the operation; 8) extensive inflammation in abdominal cavity; 9) ASA grade IV to grade V; 10) pregnant or lactating women; 11) severe cardiovascular disease, uncontrollable infection; 12) serious mental illness; 13) The patient or family member can not understand the conditions of this study.

Design outcomes

Primary

MeasureTime frame
Incidence of anastomotic leakage;

Secondary

MeasureTime frame
Incidence of anastomotic stenosis;Incidence of anastomotic bleeding;Operation time;Bleeding volume;Postoperative hospital time;Mortality rate in 30 days;Incidence of complications in 30 days;

Countries

China

Contacts

Public ContactHu Zhiqian

Shanghai Changzheng Hospital

huzq62@163.com+86 17701780599

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026